BELLUS Health DSO Ratio 2011-2026 | BLU

Annual DSO Ratio BELLUS Health

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	3.76 K	156	73.7	24.1	122	24.9	15.2

All numbers in USD currency

Maximum	Minimum	Average
3.76 K	15.2	596

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
I-Mab IMAB	271	-	-	$ 866 M	China
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	20.6	$ 0.89	-	$ 6.54 M	China
ACADIA Pharmaceuticals ACAD	37.5	$ 22.35	0.68 %	$ 3.7 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Can-Fite BioPharma Ltd. CANF	28.1	$ 3.65	22.48 %	$ 6.01 M	Israel
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Aquestive Therapeutics AQST	103	$ 4.08	0.74 %	$ 436 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	16.8	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	59	-	17.91 %	$ 11.1 M	USA
Arcutis Biotherapeutics ARQT	106	$ 22.65	1.25 %	$ 2.88 B	USA
Edesa Biotech EDSA	97.1	$ 16.23	2.08 %	$ 51.9 M	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Autolus Therapeutics plc AUTL	58.2	$ 1.42	0.71 %	$ 378 M	Britain
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Evogene Ltd. EVGN	30	$ 0.79	4.79 %	$ 27.9 M	Israel
BioDelivery Sciences International BDSI	115	-	-4.8 %	$ 255 M	USA
Exelixis EXEL	43.4	$ 45.0	0.69 %	$ 12.2 B	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands